William Murphy - Academia.edu (original) (raw)

William Murphy

Address: Fargo, United States

less

Related Authors

YIH-SHARNG CHEN

Joan Tryzelaar

H. Fatih Aşgün

Handika Tri Tawangsasi

C.A. Dézsi

Akif Ündar

PennState Hershey (Milton S. Hershey Medical Center)

Uploads

Papers by William Murphy

Research paper thumbnail of ACC/AHA 2005 Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): A Collaborative Report from the American Association for Vascular Surgery/Society for Vascular Surgery,⁎Society for Cardiovascular Angiography and In...

Journal of the American College of Cardiology, 2006

The full text is published on the ACC and AHA World Wide Web sites. Copies of the full text and t... more The full text is published on the ACC and AHA World Wide Web sites. Copies of the full text and the executive summary are available from both organizations.

Research paper thumbnail of Controlled Trial of Routine Administration of Platelet Concentrates in Cardiopulmonary Bypass Surgery

Annals of Thoracic Surgery, 1984

Prophylactic administration of platelet concentrates to patients undergoing their first cardiopul... more Prophylactic administration of platelet concentrates to patients undergoing their first cardiopulmonary bypass operation (coronary artery bypass grafting or uncomplicated valve replacement) was evaluated in a controlled randomized study of 28 patients. Four units of platelet concentrates administered at the end of bypass prevented prolongation of the bleeding time seen in patients not receiving platelets. However, chest tube blood loss, transfusion requirements, and clinical outcome were not improved. Moreover, thrombocytopenia and pmlongation of bleeding time did not correlate with blood loss or transfusion needs. Mild thmmbocytopenia (to 58,000 platelets per microliter) and transient platelet dysfunction after bypass do not require administration of platelet concentrates, and prophylactic use of this blood component in the surgical setting of bypass is not indicated.

Research paper thumbnail of ACC/AHA 2005 Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): A Collaborative Report from the American Association for Vascular Surgery/Society for Vascular Surgery,⁎Society for Cardiovascular Angiography and In...

Journal of the American College of Cardiology, 2006

The full text is published on the ACC and AHA World Wide Web sites. Copies of the full text and t... more The full text is published on the ACC and AHA World Wide Web sites. Copies of the full text and the executive summary are available from both organizations.

Research paper thumbnail of Controlled Trial of Routine Administration of Platelet Concentrates in Cardiopulmonary Bypass Surgery

Annals of Thoracic Surgery, 1984

Prophylactic administration of platelet concentrates to patients undergoing their first cardiopul... more Prophylactic administration of platelet concentrates to patients undergoing their first cardiopulmonary bypass operation (coronary artery bypass grafting or uncomplicated valve replacement) was evaluated in a controlled randomized study of 28 patients. Four units of platelet concentrates administered at the end of bypass prevented prolongation of the bleeding time seen in patients not receiving platelets. However, chest tube blood loss, transfusion requirements, and clinical outcome were not improved. Moreover, thrombocytopenia and pmlongation of bleeding time did not correlate with blood loss or transfusion needs. Mild thmmbocytopenia (to 58,000 platelets per microliter) and transient platelet dysfunction after bypass do not require administration of platelet concentrates, and prophylactic use of this blood component in the surgical setting of bypass is not indicated.

Log In